Assertio Inc. (ASRT) Business Metric Overview - Stocknear

Assertio Inc.

NASDAQ: ASRT · Real-Time Price · USD
0.81
0.01 (1.53%)
At close: Sep 08, 2025, 3:03 PM

Assertio Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
INDOCIN Products Revenue 3.03M 5.54M 21.09M 5.67M 20M 20M 10.85M 17.95M 28.07M 30.35M 34.27M 21.87M 35.43M 21.36M 18.34M 26M 13.07M 14.6M 12.48M 13.77M 5.43M 9.25M 28.92M 27.5M 25.94M 26.45M 29.34M 29.43M 26.84M 44.35M
INDOCIN Products Revenue Growth -45.29% -73.72% +272.06% -71.66% 0.00% +84.37% -39.56% -36.07% -7.48% -11.45% +56.71% -38.28% +65.89% +16.43% -29.44% +98.83% -10.43% +16.99% -9.41% +153.46% -41.27% -68.00% +5.15% +6.03% -1.94% -9.85% -0.33% +9.68% -39.49% n/a
Product Revenue 28.82M 25.99M 92.14M 28.7M 30.7M 31.86M 32.46M 35.14M 40.08M 41.77M 49.86M 34.28M n/a 35.55M 32.15M n/a 24.83M 26.41M 29.82M 34.27M 20.16M n/a n/a n/a n/a n/a n/a n/a n/a 250K
Product Revenue Growth +10.88% -71.79% +221.00% -6.48% -3.66% -1.85% -7.61% -12.34% -4.04% -16.23% +45.46% n/a n/a +10.57% n/a n/a -5.96% -11.44% -12.99% +69.93% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Product, Other Revenue 4.44M 3.56M 1.3M 214K 406K 510K 2K 12K 605K 796K 786K 884K n/a 1.64M 1.31M n/a 2.94M 1.7M 3.83M 5.64M 1.6M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Product, Other Revenue Growth +24.71% +172.87% +509.81% -47.29% -20.39% +25400.00% -83.33% -98.02% -23.99% +1.27% -11.09% n/a n/a +25.11% n/a n/a +73.36% -55.73% -32.06% +252.18% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Royalty Revenue 400K 494K 5.63M 2M 2.15M 1.44M 2.34M 2.54M 2.37M 1.89M 2.67M 2.46M n/a 1.77M 1.76M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Royalty Revenue Growth -19.03% -91.22% +181.77% -6.99% +49.41% -38.67% -7.94% +7.25% +25.62% -29.33% +8.88% n/a n/a +0.06% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
SPRIX Nasal Spray Revenue 1.98M 1.59M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
SPRIX Nasal Spray Revenue Growth +24.35% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2020 Sep 30, 2020
Canada Revenue 400K 500K 1.5M 500K 400K 600K 500K 400K 500K 400K 500K 500K 500K 300K 300K
Canada Revenue Growth -20.00% -66.67% +200.00% +25.00% -33.33% +20.00% +25.00% -20.00% +25.00% -20.00% 0.00% 0.00% +66.67% 0.00% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 16.96M 21.98M 21.52M 16.73M 18.39M 18.42M 23.46M 21M 16.77M 16.9M 13.71M 11.9M 10.54M 10.64M 13.28M 9.31M 26.23M 7.73M 21.27M 25.75M 28.13M 27.31M 22.95M 36.12M 24.75M 25.05M 25.47M 33.41M 31.31M 29.03M 48.32M 48.85M 50.01M 48.52M 48.46M 51.57M 51.9M 52.56M 58.34M 49.06M 57.41M 34.54M
Selling, General, and Administrative Revenue Growth -22.82% +2.13% +28.64% -9.02% -0.21% -21.48% +11.71% +25.25% -0.79% +23.33% +15.18% +12.87% -0.89% -19.88% +42.56% -64.50% +239.39% -63.66% -17.38% -8.48% +2.99% +19.02% -36.46% +45.90% -1.16% -1.66% -23.77% +6.71% +7.84% -39.91% -1.09% -2.32% +3.07% +0.12% -6.03% -0.63% -1.25% -9.90% +18.90% -14.53% +66.20% n/a
Research and Development Revenue 387K 438K 1.29M 1M 798K 733K 1.02M 1.32M 503K n/a n/a n/a n/a n/a n/a n/a n/a n/a 230K 1.32M 1.63M 1.04M 5.58M 1.48M 1.26M 1.79M 2.21M 2.13M 2.18M 1.53M 26.16M 1.76M 5.61M 5.08M 9.15M 10.41M 7.12M 5.95M 61.24M 4.63M 4.71M 1.86M
Research and Development Revenue Growth -11.64% -65.94% +27.96% +25.94% +8.87% -28.42% -22.19% +161.63% n/a n/a n/a n/a n/a n/a n/a n/a n/a -100.00% -82.52% -19.07% +56.20% -81.33% +277.71% +16.86% -29.56% -18.76% +3.76% -2.43% +42.67% -94.16% +1385.46% -68.63% +10.42% -44.46% -12.08% +46.32% +19.62% -90.29% +1222.96% -1.80% +153.71% n/a